Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Oral Colchicine in Argentina (ORCA Trial) for the Prevention of Adverse Events After Percutaneous Coronary Interventions

NCT04382443 is registered in ClinicalTrials.gov with Centro de estudios en Cardiologia Intervencionista as lead sponsor.

NCT NCT04382443
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04382443 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Oral Colchicine in Argentina (ORCA Trial) for the Prevention of Adverse Events After Percutaneous Coronary Interventions
Lead sponsor
Centro de estudios en Cardiologia Intervencionista
Phase
Phase 4
Overall status
Completed
Start date
March 12, 2020
Completion date
April 30, 2022
Enrollment
410 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

acute coronary syndrome, atherosclerosis, coronary artery disease, restenosis of coronary artery stent